Cardiovascular Complication Clinical Trial
Official title:
Cardiorenal Effecs of Losartan in Kidney Transplant Recipients
The influence of Losartan to cardiovascular and renal outcomes in patients after renal transplatation.
The benefits of cardio and nephroprotective properties of treatment with drugs blocking the renin angiotensin aldosterone system in the general population has already been shown. There are no data on the cardiac and renal effects of this type of treatment in patients after renal transplantation. Therefore, the observational, case-control study was designed in a population of kidney transplant recipients. The study group consists of patients treated with antihypertensive drugs including Losartan at a minimum dose of 50mg. The control group consists of patients treated with antihypertensive drugs, without the renin angiotensin aldosterone system blockade. Blood pressure will be controlled in accordance with the current recommendations. The primary aim of this study is to determine whether, in renal transplant recipients with hypertension, losartan, angiotensin II receptor antagonist improves cardiovascular and graft outcome i.e. reduces incidence of cardiovascular complications and slows progression of graft insufficiency. Secondary objective is to determine whether losartan 1. delays the occurrence of cardiovascular complications, 2. slows progression of graft insufficiency, 3. is the safe drug in renal transplant recipients, 4. decrease albuminuria and other surrogate markers of graft injury or cardiovascular involvement. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06089226 -
Parameters Related to Physical Activity Level in SCI
|
||
| Recruiting |
NCT04696081 -
Atrial Fibrillation in Active Cancer Patients
|
||
| Recruiting |
NCT05687097 -
Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
|
||
| Completed |
NCT03274869 -
Scrub Typhus Infection Induced Cardiovascular Disease
|
||
| Completed |
NCT04025086 -
Perioperative Goal Directed Therapy (PGDT) in Spinal Surgery in the Prone Position
|
||
| Completed |
NCT03010969 -
Perioperative Endothelial Dysfunction in Patients Undergoing Major Acute Abdominal Surgery
|
||
| Completed |
NCT01413815 -
Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients
|
N/A | |
| Recruiting |
NCT05077748 -
An 18-year Follow-up Study on OSA in a Population-based Cohort
|
||
| Not yet recruiting |
NCT06279000 -
Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery
|
Phase 3 | |
| Enrolling by invitation |
NCT06360666 -
Clinical Outcomes in Adult Patients Undergoing Laparoscopic Surgery Under Neuraxial Anesthesia
|
||
| Recruiting |
NCT03977337 -
Perioperative Pulmonary Monitoring in Major Emergency Surgery
|
||
| Recruiting |
NCT05996965 -
Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device
|
||
| Recruiting |
NCT05349955 -
Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
|
N/A | |
| Withdrawn |
NCT04435015 -
The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05745090 -
N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) in Type 2 Diabetes Mellitus
|
||
| Terminated |
NCT03760159 -
Minimally Invasive Detection of a Sleep Apnoea
|
||
| Completed |
NCT04802122 -
Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects.
|
Phase 4 | |
| Recruiting |
NCT05895669 -
Cardiovascular Outcomes in Orthotopic Liver Transplanted Patients (COLT Study)
|
||
| Completed |
NCT05685979 -
Evaluation of Cardiac Functions in Deep Trendelenburg Position
|
||
| Completed |
NCT03498352 -
Rest Ventilatory Parameters Predict Morbidity and Mortality in Thoracic Surgery
|